Humana Inc. (NYSE:HUM) Shares Sold by Oak Thistle LLC

Oak Thistle LLC lessened its position in shares of Humana Inc. (NYSE:HUM) by 61.8% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 1,664 shares of the insurance provider’s stock after selling 2,688 shares during the period. Oak Thistle LLC’s holdings in Humana were worth $577,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. LPL Financial LLC grew its position in shares of Humana by 1.8% in the third quarter. LPL Financial LLC now owns 28,265 shares of the insurance provider’s stock valued at $13,752,000 after purchasing an additional 505 shares during the last quarter. Schonfeld Strategic Advisors LLC grew its holdings in Humana by 11.0% during the 3rd quarter. Schonfeld Strategic Advisors LLC now owns 25,855 shares of the insurance provider’s stock valued at $12,579,000 after buying an additional 2,572 shares during the last quarter. Quadrature Capital Ltd increased its position in Humana by 814.5% during the third quarter. Quadrature Capital Ltd now owns 181,787 shares of the insurance provider’s stock worth $88,448,000 after buying an additional 161,909 shares in the last quarter. Insigneo Advisory Services LLC purchased a new stake in shares of Humana in the third quarter valued at $207,000. Finally, AQR Capital Management LLC boosted its stake in shares of Humana by 39.3% during the third quarter. AQR Capital Management LLC now owns 681,868 shares of the insurance provider’s stock valued at $331,743,000 after acquiring an additional 192,546 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have issued reports on HUM. The Goldman Sachs Group reduced their target price on shares of Humana from $450.00 to $385.00 and set a “buy” rating on the stock in a report on Wednesday, April 3rd. TD Cowen decreased their target price on shares of Humana from $427.00 to $396.00 and set a “buy” rating on the stock in a research report on Tuesday, April 2nd. Robert W. Baird began coverage on Humana in a report on Thursday, May 30th. They issued a “neutral” rating and a $374.00 price target for the company. Raymond James assumed coverage on Humana in a research note on Friday, March 22nd. They set a “market perform” rating on the stock. Finally, UBS Group lowered their price objective on Humana from $334.00 to $326.00 and set a “neutral” rating for the company in a research report on Thursday, April 25th. Fourteen investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $409.55.

Humana Trading Down 0.0 %

Shares of Humana stock traded down $0.16 during trading hours on Monday, hitting $373.49. The company’s stock had a trading volume of 975,287 shares, compared to its average volume of 1,822,593. The business has a fifty day moving average of $343.78 and a 200 day moving average of $351.23. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $530.54. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.77. The company has a market capitalization of $45.01 billion, a PE ratio of 23.26, a P/E/G ratio of 2.16 and a beta of 0.51.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, topping analysts’ consensus estimates of $6.12 by $1.11. Humana had a net margin of 1.82% and a return on equity of 17.76%. The firm had revenue of $29.61 billion during the quarter, compared to analysts’ expectations of $28.52 billion. During the same period in the prior year, the company earned $9.38 EPS. The firm’s revenue was up 10.7% on a year-over-year basis. As a group, equities analysts forecast that Humana Inc. will post 16.27 EPS for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 0.95%. The ex-dividend date is Friday, June 28th. Humana’s dividend payout ratio (DPR) is presently 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.